CAR-T

Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma
Medical Marketing and Media
Fri, 02/16/24 - 11:42 am
CAR-T
FDA
Peter Marks
CBER
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
Gilead’s Kite Gets FDA Approval for Faster CAR T Therapy Manufacturing
BioSpace
Wed, 01/31/24 - 11:58 am
Gilead Sciences
Kite Pharma
FDA
drug manufacturing
Yescarta
CAR-T
FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases
BioSpace
Thu, 01/25/24 - 11:03 am
CAR-T
cancer
FDA
Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings
Fierce Pharma
Wed, 01/24/24 - 10:46 am
Gilead Sciences
Tecartus
CAR-T
FDA
FDA requires 'boxed warning' for CAR-T cancer therapies
Reuters
Mon, 01/22/24 - 10:10 pm
CAR-T
FDA
warnings
Gilead Sciences
JNJ
Novartis
CAR-T hype faces infrastructure reality check
Fierce Pharma
Tue, 01/16/24 - 09:22 am
CAR-T
cell therapy
gene therapy
Gilead Sciences
JNJ
FDA’s CAR T Probe ‘Not a Big Deal’ for Oncology-Focused Biotechs: Triumvira President
BioSpace
Wed, 01/10/24 - 06:25 pm
oncology
CAR-T
regulatory
FDA
Allogene to shift strategy in bid to reposition CAR-T
BioPharma Dive
Fri, 01/5/24 - 10:03 am
Allogene Therapeutics
cell therapy
cancer
CAR-T
Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review
BioSpace
Wed, 12/20/23 - 09:36 am
CAR-T
FDA
cancer
Oncologists Defend CAR-T After FDA Advisory
BioSpace
Mon, 12/18/23 - 10:11 am
oncologists
CAR-T
cancer
FDA
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates
BioSpace
Fri, 12/15/23 - 11:14 am
CARsgen
FDA
cell therapy
CAR-T
ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy
Fierce Pharma
Mon, 12/11/23 - 10:55 pm
ASH 2023
Abecma
FDA
CAR-T
Bristol Myers Squibb
Novartis hit with FDA letter detailing 'significant' Kymriah manufacturing shortfalls
Fierce Pharma
Thu, 12/7/23 - 10:08 am
Novartis
FDA
Kymriah
CAR-T
drug manufacturing
‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs
Fierce Biotech
Tue, 12/5/23 - 09:46 am
BrainChild Bio
pediatric cancer
clinical trials
CAR-T
oncology
brain cancer
FDA Launches Probe of Malignancies Linked to CAR-T Therapies
BioSpace
Wed, 11/29/23 - 12:04 pm
CAR-T
side effects
FDA
Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Fierce Biotech
Mon, 11/13/23 - 11:55 am
Novartis
Legend Biotech
CAR-T
T-Charge
solid tumors
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy

Pages